# Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)

> **NCT00726713** · PHASE4 · COMPLETED · sponsor: **Pamlab, Inc.** · enrollment: 214 (actual)

## Conditions studied

- Type 2 Diabetic Peripheral Neuropathy (DPN)

## Interventions

- **OTHER:** Metanx (a medical food)
- **OTHER:** Metanx placebo

## Key facts

- **NCT ID:** NCT00726713
- **Lead sponsor:** Pamlab, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-05
- **Final completion:** 2011-06
- **Target enrollment:** 214 (ACTUAL)
- **Last updated:** 2013-08-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00726713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00726713, "Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00726713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*